<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02590120</url>
  </required_header>
  <id_info>
    <org_study_id>12.02.FR.NHS</org_study_id>
    <nct_id>NCT02590120</nct_id>
  </id_info>
  <brief_title>Enteral Nutrition and Amino Acid Absorption</brief_title>
  <acronym>PEPS</acronym>
  <official_title>Comparaison du Profil d'Absorption Des Acides aminés Entre Une Nutrition entérale Semi-élémentaire et Une Nutrition entérale polymérique</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Nestlé</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Nestlé</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to evaluate amino acid absorption with two different type of
      proteins.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>February 2015</start_date>
  <completion_date type="Anticipated">December 2017</completion_date>
  <primary_completion_date type="Anticipated">December 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Amino acid absorption profile</measure>
    <time_frame>48 hours</time_frame>
    <description>Area under the curve of amino acid plasma concentration</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Tolerance</measure>
    <time_frame>48 hours</time_frame>
    <description>Description and occurence of adverse events</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Nutritional status</measure>
    <time_frame>48 hours</time_frame>
    <description>Retinol Binding Protein and Transthyretin dosage</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Essentials amino acid absorption</measure>
    <time_frame>48 hours</time_frame>
    <description>Area under the curve of plasma concentration</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Insulinemia evolution</measure>
    <time_frame>48 hours</time_frame>
    <description>Insulinemia dosage</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Link between amino acid and insuline</measure>
    <time_frame>48 hours</time_frame>
    <description>Correlation coefficient</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">12</enrollment>
  <condition>Malabsorption</condition>
  <arm_group>
    <arm_group_label>Enteral nutrition product : product A</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Administration during 16 hours.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Enteral nutrition product : product B</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Administration during 16 hours.</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Enteral nutrition</intervention_name>
    <arm_group_label>Enteral nutrition product : product A</arm_group_label>
    <arm_group_label>Enteral nutrition product : product B</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patient with gastrointestinal disorder : citrulline plasma concentration &lt; 20 µmol/L
             and/or xylose plasma concentration &lt; 1,7 mmol/L

          -  Patient under enteral nutrition at home

          -  Patient already receiving 1 L by day

        Exclusion Criteria:

          -  Obese patient BMI &gt; 30

          -  Diabetes

          -  Renal or liver failure

          -  Glucocorticoids treatment
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Julien Gautry, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Nestle Health Science</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>CHU de Lille</name>
      <address>
        <city>Lille</city>
        <zip>59037</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Dominique Deplanque</last_name>
      <phone>+33320446891</phone>
      <email>dominique.deplanque@chru-lille.fr</email>
    </contact>
    <investigator>
      <last_name>David Seguy</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>October 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 27, 2015</study_first_submitted>
  <study_first_submitted_qc>October 27, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 28, 2015</study_first_posted>
  <last_update_submitted>October 19, 2017</last_update_submitted>
  <last_update_submitted_qc>October 19, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">October 20, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Malabsorption Syndromes</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

